Table 2. Serum SAA in non-cancer (healthy), benign disease and USPC patients.
Subject group | N | Median (95% CI)a | Rangea |
---|---|---|---|
Healthy | 51 | 6.0 (4.0–8.9) | 1.6–169.2 |
Benign disease | 42 | 6.0 (4.2–8.1) | 1.1–189.9 |
USPC | 30 | 15.6 (9.2–56.2) | 2.1–4000 |
Pairwise comparison | Area under ROC curveb | P-valuec | |
Healthy vs benign | 0.506 | 0.917 | |
Healthy vs USPC | 0.732 | 0.0005 | |
Benign vs USPC | 0.739 | 0.0006 |
Medians, 95% confidence intervals, and ranges of serum SAA are in μg ml−1.
Values near 0.50 denote highly overlapping distributions; values near 1.00 denote highly separated distributions.
P-values are from the two-sided Wilcoxon–Mann–Whitney test of the indicated comparison.